Genomic Health's Board Approves $30M Share Repurchase Program

Dec 11, 2012

|

NEW YORK (GenomeWeb News) – Genomic Health's board has approved a $30 million share repurchase program, the Redwood City, Calif.-based firm said in a document filed with the US Securities and Exchange Commission today.

Repurchases made under the program will be funded using the firm's working capital. As of Sept. 30, Genomic Health had cash and cash equivalents, and investments and marketable securities totaling $127 million. It had about 30.8 million shares of common stock outstanding as of Nov. 30.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Featured White Papers

STARLIMS Quality Manufacturing Solution Interfacing with 3rd party systems

STARLIMS Biorepository Solution Helps Fortune 200 Company Boost Efficiency, Cost Effectiveness, And Increase Sample Management By 25 Percent

ABBOTT Informatics STARLIMS Solution Helps Precision Diagnostics Achieve Compliance and Retain Customers

Meeting Modern Data Integrity and Compliance Requirements

Jun

14

Featured Webinar

Overcoming Challenges in Hematological Genomic Testing with Advanced AI

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun

19

Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun

20

Featured Webinar

Expert Tips on Sequencing and Library Prep from the Wellcome Sanger Institute

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun

28

Featured Webinar

An Optimized NGS Workflow for Human Metagenomic Analysis

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.

Main menu